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Hepatitis E vaccine was available in China in 2012, but the priority population for immunization is not
clear. In 2013, a hepatitis E outbreak occurred in a company of Shandong province, China where most
employees moved from other provinces and dined at the company’s cafeteria. A total of fourteen (19%,
14/73) case-patients were identified, and three of them had symptomatic infection with one death.
The proportion of symptomatic infection was much higher among those agedP50 years than those aged
<50 years (2/2 vs. 1/12, P = 0.03), and higher in males than females (3/8 vs. 0/6, P = 0.21). Food in the com-
pany’s cafeteria might be the possible source of the outbreak. The findings from this outbreak investiga-
tion indicate that individuals agedP50 years, particularly males, might be the population of top priority
for hepatitis E vaccination in China.
 2016 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hepatitis E virus (HEV) is an enterically transmitted virus, and
outbreaks from HEV was first verified and confirmed in 1990 s
[1] and is responsible for about 50% of acute viral hepatitis cases
in the endemic countries [2,3]. HEV is endemic in China and the
seroprevalence among the general population was around 23%
[4]. Hepatitis E cases are required to report to the National Notifi-
able Reporting System (NNDRS) in China since 1997, and the num-
ber of reported cases increased from 16,444 in 2004 to 19,202 in
2011[5]. In 2012, hepatitis E vaccine became available in China,
and offered an effective way to prevent HEV infection [6]; but
the vaccination coverage is still very low.
Between December 2013 and January 2014, a hepatitis E out-
break occurred in a company in Donggang District, Rizhao Prefec-
ture of Shandong province, China. We reported the HEV outbreak,
and examined risk factors associated with HEV infection, and
explored the implications for hepatitis E prevention.
2. Methods
2.1. General information of the company
Donggang District of Rizhao Prefecture was located in the east
of China, having a population of 78,000. The company where theoutbreak occurred was established in Rizhao city in December
2011. There were 73 employees in the company, including 69
employees moved from other provinces of China during December
2011 and October 2012 and four local employees (two cooks and
two janitors). All migrant employees lived in the apartments near
the company. Free bottled water from dispensers was available in
apartments and the offices. The company had a cafeteria which
opened all day long for three meals.
2.2. Active case-finding
To identify all persons infected with HEV in the company, blood
and stool samples were collected from all employees and were
tested for HEV IgM and HEV IgG. The IgM-positive employees
who developed signs and symptoms compatible with hepatitis
were reported to NNDRS. Face-to-face interviews were conducted
for all local employees and their family members on whether they
had developed signs and symptoms indicative for hepatitis in the
past two months. If any family had any sign/symptom for hepatitis,
blood and stool samples would be collected and tested for HEV
infection.
2.3. Case investigation
A face-to-face interview was conducted among HEV
IgM-positive employees. Information on demographics information
and the potential risk factors during the potential exposure period
(from October 1, 2013 to November 15, 2013, 15–60 days prior to
the disease onset of the index case) was collected, including the
Table 1
The prevalence of HEV IgM and HEV IgG among the employees by age, gender and
employee types.
No.
tested
HEV IgM
positive
HEV IgG
positive
Symptomatic
hepatitisa
n (%) n (%) n (%b)
Total 73 14 (19) 14 (19) 3 (21)
Age (years)
20–49 67 12 (18) 12 (18) 1 (8)
P50 6 2 (33) 2 (33) 2 (100)
Gender
Male 45 8 (18) 8 (18) 3 (38)
Female 28 6 (21) 6 (21) 0 (0)
Employee types
Local
employee
4 1 (25) 1 (25) 0 (0)
No-local
employee
69 13 (19) 13 (19) 3 (23)
a Defined as HEV IgM+ with signs and symptoms for hepatitis.
b The denominator was the number of the employees who were HEV IgM+.
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Fig. 1. Phylogenetic tree based on partial open reading frame (ORF) sequences of the hep
the neighbor joining method. Genetic distances were calculated using the Kimura two-p
3716 L. Zhang et al. / Vaccine 34 (2016) 3715–3718histories of diet, drinking water, travel, contact with other persons
infected with HEV, transplantation and transfusion and the clinical
information including the date of disease onset, the symptoms and
signs. The medical records were checked for those who were hos-
pitalized to verify their clinical information. Verbal informed con-
sents were obtained from all employees before interview and
sample collection.
2.4. Laboratory testing
The blood samples were tested for HEV IgM and IgG using Wan-
tai ELISA kit (Wantai Biological, Beijing, China) according to the
manufactory’s instructions. The sera and the stool samples from
HEV IgM-positive employees were analyzed for HEV RNA by
reverse transcription-nested PCR with primers designed within
644-bp region of open reading frame (ORF) 2 [7]. Phylogenetic
analysis with 594 nt sequences of the ORF2 was performed to
determine the HEV genotype using Mega 4.0 and the nucleotide
similarity among the HEV isolations in the outbreak and other KF176351/china/swine/4d
 ▲SDHEV002/China/human/4d
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 GU361892/china/swine/4d
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arameter method.
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collected because the cafeteria had been thoroughly sanitized
before investigation.
2.5. Data analysis
HEV recent acute infection was defined as positive HEV IgM,
and symptomatic hepatitis E was defined as recent acute HEV
infection with signs and symptoms compatible with hepatitis
including acute jaundice, dark urine, anorexia, malaise, extreme
fatigue and right upper quadrant tenderness. The distributions of
HEV recent acute infection were examined by age and gender using
Fisher’s exact test and P < 0.05 was regarded as statistically
significant.
3. Results
Fourteen (19%, 14/73) employees were positive for HEV IgM as
defined as recent acute infection. There was no difference in the
attack rates between those aged <50 and P50 years (18% vs. 33%,
P = 0.32), between males and females (18% vs. 21%, P = 0.76), or
between the local and migrant employees (19%vs. 25%, P = 1.00)
(Table 1).
Three employees were diagnosed with symptomatic hepatitis.
The index case became ill on December 1, 2013 and died on Jan-
uary 9, 2014. The other two had disease onset on December 30,
2013 and January 9, 2014, respectively, and fully recovered soon.
The clinical characteristics of these cases were shown in Table 2.
The proportion of symptomatic infection was much higher among
those aged P50 years than those aged <50 years (2/2 vs. 1/12,
P = 0.03), and higher in males than females (3/8 vs. 0/6, P = 0.21).
Moreover, a cook of the company was positive for HEV IgM and
her husband developed symptoms of hepatitis on January 5,
2014 and was diagnosed as symptomatic hepatitis E.
Four samples, three from symptomatic cases including the
cook’s husband and one from an asymptomatic case, showed pos-
itive for HEV RNA. The sequence data had been submitted to Gen-
bank (Accession No. KT873295, KT873296, KT873297 and
KT873298). All of them were classified into genotype 4, subgeno-
type d and the nucleotide similarity were 96–98% among them.
The strains were also closely related to the strains KF176351Table 2
Clinical and demographic characteristics of the 4 symptomatic hepatitis E outbreak cases
Characteristic Case 1a Case 2
Age, year/gender 51/Male 51/Ma
Date of symptom onset Dec 1, 2013 Dec 30
Symptoms General malaise, fatigue, inappetence, dark
urine, jaundice
Fever,
dark u
ALT on admission, IU/L 9 580
AST on admission, IU/L 1649 40
TBil on admission, umol/L 303.66 30
Duration of hospitalization
(days)
9 9
Clinical outcome Death Recove
Anti-HEV IgM Positivec Positiv
Anti-HEV IgG Positivec Positiv
HEV RNA NA Positiv
HEV isolate no. NA SDHEV
HBsAgc Negative Negati
IgM anti-HAVc Negative Negati
Anti-HCVc Negative Negati
NA: not applicable.
a The death.
b The husband of the cook.
c The results were obtained from medical records in the hospital.(Nucleotide similarity: 96.6–98.6%), KC16335 (Nucleotide
similarity: 96.0–97.3%) and GU361892 (Nucleotide similarity:
94.6–96.0%), all of which were isolated from the swine of
China (Fig. 1).
All HEV IgM-positive employees drank the bottled water pro-
vided by the company and usually dined in the cafeteria of the
company, but most of them could not provide the details of the
food. Thirty-two dinners outside the cafeteria were reported,
but no dinner even included all IgM-positive employees. The
IgM-positive cook frequently brought the food leftovers from the
cafeteria and shared with her husband. No common travel history
was found and nobody reported the histories of transfusion or
transplantation.4. Discussion
The determination of immunity to HEV usually depends on the
detection of HEV IgG and antibody concentrations of 20 Walter
Reed Units/mL are protective [8]. In this outbreak, all HEV
IgG-positive employees had positive results for HEV IgM, which
suggested that all employees in the company were negative for
HEV IgG or only had low concentration of HEV IgG before the
outbreak. This might be an important reason for the outbreak.
In this outbreak, field investigation indicated that the HEV par-
enteral transmission might not the cause for this outbreak because
no histories of transfusion or transplantation were reported. The
transmission via contamination of drinking water might be impos-
sible as the same water company supplied lots of local residents of
Donggang District, and the number of hepatitis E cases reported to
NNDRS during December 2013 and January 2014 was similar to
what reported in the same period of past year in Donggang District.
Moreover, the waterborne HEV usually is genotype 1 or 2 [9] while
HEV in this outbreak is genotype 4. The contaminated food in the
cafeteria might be the possible source of outbreak as all employees
infected with HEV dined in the cafeteria during the potential expo-
sure period and there was no meals outside of the cafeteria
involved all IgM-positive persons. Moreover, the appearance of
the case for the cook’s husband who often ate the foods from the
cafeteria during the same period further provided evidence that
the foods in the cafeteria might have been contaminated with HEV.in Rizhao, Shandong Province, China.
Case 3b Case 4
le 42/Male 25/Male
, 2013 Jan 5, 2014 Jan 9, 2014
inappetence, jaundice,
rine
Fever, inappetence, nauseating,
dark urine
Diarrhea, dark
urine
839 104
356 43
132.39 25.8
33 10
ry rapidly Recovery after artificial liver
treatment
Recovery
rapidly
e Positive Positive
e Positive Positive
e Positive Positive
001 SDHEV002 SDHEV003
ve Negative Negative
ve Negative Negative
ve Negative Negative
3718 L. Zhang et al. / Vaccine 34 (2016) 3715–3718The four HEV strains isolated in this outbreak were closely
related with the other strains obtaining from Shandong province
of China, indicating that the individuals were infected by local
strains. Although epidemiological data showed the outbreak was
common-source, the molecular data suggested the cases were
infected with closely related but different HEV strains [10,11]. It
was difficult for the cases to recall the details of the food because
of the long incubation period of the disease. According to the cafe-
teria’s menu, seafood, pork and pig liver were provided before the
outbreak, all of them had been reported as sources of HEV outbreak
[12–14].
HEV infection can be asymptomatic or symptomatic, which
could be severe or even life-threatening. In this outbreak, the pro-
portion of symptomatic infection among all cases identified was
similar to previous reports in China [9,10]. Moreover, the higher
proportion of symptomatic infection among those aged above
50 years, including the death case, indicates elder population
might be more likely to develop severe outcomes after HEV infec-
tion. All symptomatic HEV-infected individuals were males in the
outbreak, which was in accordance with the previous study [15].
Therefore, those aged P50 years, particularly males, might be
the population of top priority for vaccination in order to mitigate
severe outcomes, in addition to reduce HEV infection.
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